NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

IRIX

IRIDEX Corp

Jul 01 • 09:47AM ET

0.9430

Dollar change +0.0611
Percentage change 6.93	%

Healthcare • Medical Devices • USA • NASD

Peers: ALGN COO EW SYK BSX STAA CUTR ZBH GKOS PAVM

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.43	Insider Own	29.34%	Shs Outstand	16.79M	Perf Week	-0.56%
Market Cap	15.84M	Forward P/E	-	EPS next Y	-	Insider Trans	3.75%	Shs Float	11.86M	Perf Month	-5.51%
Enterprise Value	19.90M	PEG	-	EPS next Q	-	Inst Own	18.74%	Short Float	2.78%	Perf Quarter	-4.75%
Income	-7.13M	P/S	0.32	EPS this Y	-	Inst Trans	-1.41%	Short Ratio	4.19	Perf Half Y	-43.53%
Sales	48.80M	P/B	18.58	EPS next Y	-	ROA	-20.88%	Short Interest	0.33M	Perf YTD	-43.87%
Book/sh	0.05	P/C	2.19	EPS next 5Y	-	ROE	-194.33%	52W High	2.41 -60.84%	Perf Year	-56.34%
Cash/sh	0.43	P/FCF	-	EPS past 3/5Y	-16.95% 3.36%	ROIC	-64.65%	52W Low	0.78 20.59%	Perf 3Y	-65.58%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-3.35% 2.30%	Gross Margin	40.67%	Volatility	4.53% 4.59%	Perf 5Y	-57.14%
Dividend TTM	-	EV/Sales	0.41	EPS Y/Y TTM	36.09%	Oper. Margin	-10.69%	ATR (14)	0.05	Perf 10Y	-89.07%
Dividend Ex-Date	-	Quick Ratio	1.27	Sales Y/Y TTM	-2.24%	Profit Margin	-14.61%	RSI (14)	47.12	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.95	EPS Q/Q	52.70%	SMA20	-0.30%	Beta	0.57	Target Price	2.00
Payout	-	Debt/Eq	13.29	Sales Q/Q	1.15%	SMA50	-8.79%	Rel Volume	0.01	Prev Close	0.88
Employees	93	LT Debt/Eq	11.98	Earnings	May 13 AMC	SMA200	-32.36%	Avg Volume	78.56K	Price	0.94
IPO	Feb 16, 1996	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	118	Change	6.93%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-03-17	Resumed	ROTH Capital	Buy
Dec-21-16	Initiated	ROTH Capital	Buy
Jan-26-16	Initiated	Singular Research	Buy	$11.50
Jan-03-07	Initiated	First Albany	Buy	$15.50

Jun-30-25 06:45AM	Vicarious Surgical Announces Election of New Directors (Business Wire)
Jun-24-25 07:00AM	Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema (GlobeNewswire)
May-14-25 03:17AM	IRIDEX Corp (IRIX) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Investments ... (GuruFocus.com) -9.09%
May-13-25 04:33PM	Iridex: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports First Quarter 2025 Financial Results (GlobeNewswire)
06:00PM	Loading…
May-01-25 06:00PM	IRIDEX Changes Course (Seeking Alpha)
Apr-30-25 04:05PM	Iridex to Report First Quarter 2025 Financial Results on May 13, 2025 (GlobeNewswire)
Apr-16-25 07:11PM	IRIDEX Corporation (IRIX) Strategic Vision Conference Call (Transcript) (Seeking Alpha)
Apr-14-25 04:05PM	Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025 (GlobeNewswire) +5.04%
Apr-09-25 04:05PM	Iridex to Host Strategic Vision Call on April 16, 2025 (GlobeNewswire) +10.67%
Mar-28-25 08:48AM	Q4 2024 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents) +13.15%
03:04AM	IRIDEX Corp (IRIX) Q4 2024 Earnings Call Highlights: Strategic Investments and Revenue Growth ... (GuruFocus.com)
Mar-27-25 06:03PM	IRIDEX Corporation (IRIX) Q4 2024 Earnings Call Transcript (SeekingAlpha)
04:36PM	Iridex: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
09:15AM	Loading…
Mar-19-25 09:15AM	Iridex Announces Strategic Investment in the Company (GlobeNewswire) -20.79%
Mar-14-25 07:00AM	Iridex Comments on Recent Stock Price Volatility (GlobeNewswire) +16.49%
Mar-13-25 05:00PM	Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 (GlobeNewswire) -21.14%
Jan-14-25 07:24AM	Iridex: Q4 Sales To Match Performance Of Prior Year (RTT News)
07:00AM	Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024 (GlobeNewswire)
Dec-18-24 04:05PM	Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management (GlobeNewswire)
Nov-19-24 08:14AM	Iridex Comments on Changing Glaucoma Reimbursement Landscape (GlobeNewswire)
Nov-13-24 02:20AM	IRIDEX Corp (IRIX) Q3 2024 Earnings Call Highlights: Strategic Moves and Glaucoma Growth Amid ... (GuruFocus.com) +34.04%
Nov-12-24 04:40PM	Iridex: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-04-24 04:05PM	Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024 (GlobeNewswire) -5.02%
Oct-09-24 05:59PM	IRIDEX Corp (IRIX) Q2 2024 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com) -6.96%
Oct-03-24 04:05PM	Iridex Appoints Patrick Mercer as Chief Executive Officer (GlobeNewswire)
Aug-08-24 09:57PM	IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q2 2024 (InvestorPlace)
06:15PM	Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
05:13PM	Loading…
05:13PM	Iridex: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-05-24 08:00AM	Iridex Announces Convertible Note Financing (GlobeNewswire) -9.74%
Jul-30-24 04:05PM	Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024 (GlobeNewswire)
May-15-24 07:46AM	Q1 2024 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents) -13.96%
03:12AM	IRIDEX Corp (IRIX) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ... (GuruFocus.com)
May-14-24 06:00PM	Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:55PM	Iridex: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-08-24 04:05PM	Iridex to Report First Quarter 2024 Financial Results on May 14, 2024 (GlobeNewswire)
Mar-27-24 10:39AM	IRIDEX Corporation (NASDAQ:IRIX) Q4 2023 Earnings Call Transcript (Insider Monkey) +17.53%
10:10AM	Q4 2023 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents)
Mar-26-24 08:53PM	IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
06:05PM	Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
05:06PM	Iridex: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-20-24 04:05PM	Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024 (GlobeNewswire)
Feb-06-24 08:00AM	Iridex Corporation Receives European Patent on MicroPulse Technology (GlobeNewswire)
Jan-24-24 08:00AM	Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust (GlobeNewswire)
Jan-11-24 06:45PM	Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma (GlobeNewswire)
Dec-28-23 06:00PM	Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation (GlobeNewswire)
Nov-27-23 09:00AM	Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation (GlobeNewswire) +19.00%
Nov-14-23 05:06PM	Iridex: Q3 Earnings Snapshot (Associated Press Finance) -7.32% +6.84%
04:21PM	Iridex Reports Third Quarter 2023 Financial Results and Business Update (GlobeNewswire)
Nov-13-23 09:00AM	Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023 (GlobeNewswire)
Oct-26-23 04:22PM	Iridex to Report Third Quarter Financial Results on November 14, 2023 (GlobeNewswire)
Aug-29-23 04:05PM	Iridex Announces Strategic Review to Unlock Shareholder Value (GlobeNewswire) +6.57% +13.70%
Aug-11-23 06:59AM	Q2 2023 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents) -28.25%
Aug-10-23 06:30PM	Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
05:23PM	Iridex: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-09-23 08:46AM	We Think IRIDEX (NASDAQ:IRIX) Needs To Drive Business Growth Carefully (Simply Wall St.)
Jul-27-23 04:05PM	Iridex to Report Second Quarter Financial Results on August 10, 2023 (GlobeNewswire)
Jun-21-23 05:00AM	Zacks Industry Outlook Highlights IPG Photonics and IRIDEX (Zacks)
Jun-20-23 12:25PM	2 Laser Systems Stocks to Buy in a Prospering Industry (Zacks)
Jun-08-23 07:06AM	IRIDEX Corporation's (NASDAQ:IRIX) Price Is Right But Growth Is Lacking (Simply Wall St.)
May-18-23 08:50AM	Iridex (IRIX) Is Attractively Priced Despite Fast-paced Momentum (Zacks)
May-12-23 06:37AM	Q1 2023 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents)
May-11-23 06:05PM	Iridex (IRIX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:56PM	Iridex: Q1 Earnings Snapshot (AP Finance)
04:05PM	Iridex Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-27-23 04:05PM	Iridex to Report First Quarter Financial Results on May 11, 2023 (GlobeNewswire)
Apr-21-23 02:37PM	10 Best Humane Stocks to Buy Now (Insider Monkey)
Apr-12-23 07:00AM	Multiple insiders bought IRIDEX Corporation (NASDAQ:IRIX) stock earlier this year, a positive sign for shareholders (Simply Wall St.)
Mar-13-23 01:58AM	IRIDEX Corporation (NASDAQ:IRIX) Q4 2022 Earnings Call Transcript (Insider Monkey) +5.10%
Mar-10-23 06:27AM	Q4 2022 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents) -9.07%
Mar-09-23 05:55PM	Iridex (IRIX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Iridex Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-07-23 04:05PM	Iridex to Present at the 35th Annual Roth Conference (GlobeNewswire)
Mar-02-23 09:00AM	Iridex Introduces New Research and Showcases Five Events at the AGS Meeting (GlobeNewswire)
07:26AM	We're Keeping An Eye On IRIDEX's (NASDAQ:IRIX) Cash Burn Rate (Simply Wall St.)
Feb-23-23 04:05PM	Iridex to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023 (GlobeNewswire)
Jan-10-23 04:05PM	Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2022 (GlobeNewswire) +6.10%
Dec-06-22 05:07PM	Iridex to Participate in Fireside Chat with Stifel Equity Research (GlobeNewswire)
Nov-13-22 07:48AM	IRIDEX Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-10-22 06:35PM	Iridex (IRIX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Iridex Announces Record Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-03-22 06:53AM	A number of insiders bought IRIDEX Corporation (NASDAQ:IRIX) stock last year, which is great news for shareholders (Simply Wall St.)
Oct-27-22 04:05PM	Iridex to Report Third Quarter 2022 Financial Results on November 10, 2022 (GlobeNewswire)
Sep-29-22 04:05PM	Iridex Showcases its Non-Incisional Treatments for Glaucoma, Introduces Sweep Management Software, and Hosts 8 Physician Presentations at AAO 2022 (GlobeNewswire)
Sep-23-22 07:55AM	We're Hopeful That IRIDEX (NASDAQ:IRIX) Will Use Its Cash Wisely (Simply Wall St.)
Sep-07-22 05:09PM	12 Best Medical Device Stocks To Buy Now (Insider Monkey) +6.05%
Aug-18-22 04:05PM	Iridex to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase (GlobeNewswire) +5.93%
Aug-15-22 05:25PM	Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -13.25%
04:05PM	Iridex Announces Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-09-22 08:36AM	IRIDEX (NASDAQ:IRIX) adds US$5.1m to market cap in the past 7 days, though investors from five years ago are still down 61% (Simply Wall St.)
Aug-01-22 04:05PM	Iridex to Report Second Quarter 2022 Financial Results on August 15, 2022 (GlobeNewswire)
Jul-27-22 02:49PM	The Feds rate hike means mortgage rates are going to continue to rise: Economist (Yahoo Finance Video) +12.22%
Jun-14-22 09:21AM	Iridex Obtains Regulatory Clearance for Cyclo G6® Glaucoma Platform in China (GlobeNewswire)
May-12-22 06:05PM	Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)

IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MOORE WILLIAM M	Director	Jun 13 '25	Buy	0.97	20,000	19,372	188,650	Jun 16 01:44 PM
Mercer Patrick	President and CEO	Jun 13 '25	Buy	0.96	250	240	386,730	Jun 13 02:43 PM
MOORE WILLIAM M	Director	Jun 12 '25	Buy	0.97	20,000	19,494	168,650	Jun 13 01:28 PM
MOORE WILLIAM M	Director	Jun 11 '25	Buy	0.96	10,000	9,627	148,650	Jun 13 01:28 PM
Dizon Romeo R	Chief Financial Officer	Jun 11 '25	Buy	0.96	245	236	15,245	Jun 11 08:16 PM
Dizon Romeo R	Chief Financial Officer	Jun 09 '25	Buy	0.99	500	495	14,665	Jun 10 06:32 PM
Dizon Romeo R	Chief Financial Officer	Jun 10 '25	Buy	0.98	335	327	15,000	Jun 10 06:32 PM
Dizon Romeo R	Chief Financial Officer	Jun 06 '25	Buy	0.97	1,500	1,455	14,165	Jun 06 07:07 PM
Dizon Romeo R	Chief Financial Officer	Jun 02 '25	Buy	1.00	100	100	12,565	Jun 03 07:18 PM
Dizon Romeo R	Chief Financial Officer	Jun 03 '25	Buy	0.99	100	99	12,665	Jun 03 07:18 PM
Dizon Romeo R	Chief Financial Officer	May 29 '25	Buy	0.98	200	197	12,465	May 29 08:10 PM
Dizon Romeo R	Chief Financial Officer	May 28 '25	Buy	0.95	200	190	12,265	May 28 07:28 PM
Dizon Romeo R	Chief Financial Officer	May 27 '25	Buy	1.00	100	100	12,065	May 27 08:01 PM
Dizon Romeo R	Chief Financial Officer	May 23 '25	Buy	1.00	100	100	11,965	May 27 05:21 PM
Dizon Romeo R	Chief Financial Officer	May 22 '25	Buy	1.00	200	201	11,865	May 22 05:05 PM
MOORE WILLIAM M	Director	May 14 '25	Buy	1.10	15,000	16,506	136,150	May 16 01:38 PM
MOORE WILLIAM M	Director	May 15 '25	Buy	1.00	2,500	2,502	138,650	May 16 01:38 PM
Dizon Romeo R	Chief Financial Officer	May 14 '25	Buy	1.10	460	506	11,665	May 15 05:20 PM
Dizon Romeo R	Chief Financial Officer	May 13 '25	Buy	1.11	1,305	1,451	11,205	May 13 05:35 PM
Dizon Romeo R	Chief Financial Officer	May 12 '25	Buy	1.16	100	116	9,900	May 12 05:53 PM
Dizon Romeo R	Chief Financial Officer	May 09 '25	Buy	1.15	100	115	9,800	May 09 04:46 PM
Dizon Romeo R	Chief Financial Officer	May 08 '25	Buy	1.15	100	115	9,700	May 08 05:48 PM
Dizon Romeo R	Chief Financial Officer	May 07 '25	Buy	1.15	193	222	9,600	May 07 06:29 PM
Dizon Romeo R	Chief Financial Officer	May 06 '25	Buy	1.17	200	235	9,407	May 06 05:51 PM
Dizon Romeo R	Chief Financial Officer	May 05 '25	Buy	1.19	200	237	9,207	May 05 06:34 PM
MOORE WILLIAM M	Director	Apr 29 '25	Buy	1.21	19,710	23,784	121,150	Apr 30 03:16 PM
MOORE WILLIAM M	Director	Apr 28 '25	Buy	1.24	290	360	101,440	Apr 30 03:16 PM
Dizon Romeo R	Chief Financial Officer	Apr 29 '25	Buy	1.23	3,907	4,807	9,007	Apr 29 07:42 PM
Dizon Romeo R	Chief Financial Officer	Apr 28 '25	Buy	1.28	2,625	3,362	5,100	Apr 28 06:35 PM
Mercer Patrick	President and CEO	Apr 28 '25	Buy	1.29	7,500	9,705	400,790	Apr 28 05:18 PM
Mercer Patrick	President and CEO	Apr 24 '25	Buy	1.15	46	53	393,290	Apr 28 05:18 PM
Dizon Romeo R	Chief Financial Officer	Apr 25 '25	Buy	1.18	975	1,150	2,475	Apr 25 02:53 PM
Shuda Scott	Director	Apr 24 '25	Buy	1.20	21,457	25,748	129,523	Apr 25 11:39 AM
Dizon Romeo R	Chief Financial Officer	Apr 24 '25	Buy	1.20	500	600	1,500	Apr 24 05:51 PM
Dizon Romeo R	Chief Financial Officer	Apr 23 '25	Buy	1.11	500	555	1,000	Apr 24 05:51 PM
HUSS BEVERLY A	Director	Apr 23 '25	Buy	1.22	25,900	31,500	92,639	Apr 24 04:21 PM
MOORE WILLIAM M	Director	Apr 22 '25	Buy	1.08	10,000	10,831	101,150	Apr 23 07:10 PM
MOORE WILLIAM M	Director	Apr 21 '25	Buy	1.05	10,000	10,540	91,150	Apr 23 07:10 PM
Dizon Romeo R	Chief Financial Officer	Apr 21 '25	Buy	1.05	500	525	500	Apr 22 01:00 PM
Grove Robert Earle	Director	Apr 21 '25	Proposed Sale	0.92	8,000	7,372		Apr 21 04:48 PM
Grove Robert Earle	Director	Apr 17 '25	Proposed Sale	0.92	8,000	7,335		Apr 17 05:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IRIX

IRIDEX Corp

Upgrade your FINVIZ experience